Literature DB >> 12117933

Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection.

A Talvani1, F S Machado, G C Santana, A Klein, L Barcelos, J S Silva, M M Teixeira.   

Abstract

The production of nitric oxide (NO) by gamma interferon (IFN-gamma)-activated macrophages is a major effector mechanism during experimental Trypanosoma cruzi infection. In addition to IFN-gamma, chemoattractant molecules, such as platelet-activating factor (PAF) and CC chemokines, may also activate macrophages to induce NO and mediate the killing of T. cruzi in an NO-dependent manner. Here we investigated the ability of leukotriene B(4) (LTB(4)) to induce the production of NO by macrophages infected with T. cruzi in vitro and whether NO mediated LTB(4)-induced parasite killing. The activation of T. cruzi-infected but not naive murine peritoneal macrophages with LTB(4) induced the time- and concentration-dependent production of NO. In addition, low concentrations of LTB(4) acted in synergy with IFN-gamma to induce NO production. The NO produced mediated LTB(4)-induced microbicidal activity in macrophages, as demonstrated by the inhibitory effects of an inducible NO synthase inhibitor. LTB(4)-induced NO production and parasite killing were LTB(4) receptor dependent and were partially blocked by a PAF receptor antagonist. LTB(4) also induced significant tumor necrosis factor alpha (TNF-alpha) production, and blockade of TNF-alpha suppressed LTB(4)-induced NO release and parasite killing. A blockade of LTB(4) or PAF receptors partially inhibited IFN-gamma-induced NO and TNF-alpha production but not parasite killing. Finally, daily treatment of infected mice with CP-105,696 was accompanied by a significantly higher level of blood parasitemia, but not lethality, than that seen in vehicle-treated animals. In conclusion, our results suggest a role for LTB(4) during experimental T. cruzi infection. Chemoattractant molecules such as LTB(4) not only may play a major role in leukocyte migration into sites of inflammation in vivo but also, in the event of an infection, may play a relevant role in the activation of recruited leukocytes to kill the invading microorganism in an NO-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117933      PMCID: PMC128190          DOI: 10.1128/IAI.70.8.4247-4253.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Distribution of leukotriene B4 receptors in human hematopoietic cells.

Authors:  V R Dasari; J Jin; S P Kunapuli
Journal:  Immunopharmacology       Date:  2000-07-20

2.  Blockade of PAF receptors controls interleukin-8 production by regulating the activation of neutrophil CD11/CD18.

Authors:  B T Au; M M Teixeira; P D Collins; T J Williams
Journal:  Eur J Pharmacol       Date:  2001-08-03       Impact factor: 4.432

Review 3.  Leukotriene B4: metabolism and signal transduction.

Authors:  T Yokomizo; T Izumi; T Shimizu
Journal:  Arch Biochem Biophys       Date:  2001-01-15       Impact factor: 4.013

4.  Tissue tropism of different Trypanosoma cruzi strains.

Authors:  R C Melo; Z Brener
Journal:  J Parasitol       Date:  1978-06       Impact factor: 1.276

5.  Inhibition of activation of human peripheral blood eosinophils by Y-24180, an antagonist to platelet-activating factor receptor.

Authors:  H Komatsu; M Amano; S Yamaguchi; K Sugahara
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

6.  Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat.

Authors:  D G Souza; D C Cara; G D Cassali; S F Coutinho; M R Silveira; S P Andrade; S P Poole; M M Teixeira
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

7.  Mechanical stress and nitric oxide influence leukotriene production in cartilage.

Authors:  B Fermor; B Haribabu; J B Weinberg; D S Pisetsky; F Guilak
Journal:  Biochem Biophys Res Commun       Date:  2001-07-20       Impact factor: 3.575

8.  Lipid mediator class switching during acute inflammation: signals in resolution.

Authors:  B D Levy; C B Clish; B Schmidt; K Gronert; C N Serhan
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

9.  Stimulatory effects of leukotriene B4 on macrophage association with and intracellular destruction of Trypanosoma cruzi.

Authors:  J J Wirth; F Kierszenbaum
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).

Authors:  J S Silva; D R Twardzik; S G Reed
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  23 in total

1.  New drugs for neglected infectious diseases: Chagas' disease.

Authors:  Fabiana S Machado; Herbert B Tanowitz; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

2.  Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase.

Authors:  Carlos H C Serezani; David M Aronoff; Sonia Jancar; Peter Mancuso; Marc Peters-Golden
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

Review 3.  Bioactive lipids in Trypanosoma cruzi infection.

Authors:  Fabiana S Machado; Shankar Mukherjee; Louis M Weiss; Herbert B Tanowitz; Anthony W Ashton
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

4.  Intrapulmonary administration of leukotriene B4 enhances pulmonary host defense against pneumococcal pneumonia.

Authors:  Peter Mancuso; Casey Lewis; Carlos Henrique Serezani; Deepti Goel; Marc Peters-Golden
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

Review 5.  Too much of a good thing: How modulating LTB4 actions restore host defense in homeostasis or disease.

Authors:  Stephanie L Brandt; C Henrique Serezani
Journal:  Semin Immunol       Date:  2017-10       Impact factor: 11.130

Review 6.  Patatin-like phospholipases in microbial infections with emerging roles in fatty acid metabolism and immune regulation by Apicomplexa.

Authors:  Sarah K Wilson; Laura J Knoll
Journal:  Mol Microbiol       Date:  2017-11-23       Impact factor: 3.501

Review 7.  The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection.

Authors:  Theodoros Kelesidis; Vasiliki Papakonstantinou; Paraskevi Detopoulou; Elizabeth Fragopoulou; Maria Chini; Marios C Lazanas; Smaragdi Antonopoulou
Journal:  AIDS Rev       Date:  2015 Oct-Dec       Impact factor: 2.500

Review 8.  Convergence of nitric oxide and lipid signaling: anti-inflammatory nitro-fatty acids.

Authors:  Paul R S Baker; Francisco J Schopfer; Valerie B O'Donnell; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2008-12-10       Impact factor: 7.376

9.  Platelet-activating factor receptor deficiency delays elimination of adult worms but reduces fecundity in Strongyloides venezuelensis-infected mice.

Authors:  Deborah Negrão-Corrêa; Danielle G Souza; Vanessa Pinho; Michele M Barsante; Adriano L S Souza; Mauro M Teixeira
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Regulation of TNFalpha and IL1beta in rheumatoid arthritis synovial fibroblasts by leukotriene B4.

Authors:  Shaohua Xu; Houshan Lu; Jianhao Lin; Zhankun Chen; Dongfang Jiang
Journal:  Rheumatol Int       Date:  2009-10-07       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.